Europe — EMA

Oxaliplatin Medac

Oxaliplatin, the active ingredient in Oxaliplatin Medac, is an alkylating agent presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Medac, is an alkylating agent presented as a sterile powder for intravenous infusion use. It treats colorectal cancer and is administered in adult patients undergoing chemotherapy regimens.

GNH USA supplies Oxaliplatin Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Medac is an alkylating agent used in the treatment of cancers that respond to platinum‑based chemotherapy. - Colorectal cancer: Enhances the efficacy of combination chemotherapy regimens. - Gastric cancer: Used in combination with other agents to improve response rates. - Pancreatic cancer: Contributes to tumor size reduction when combined with multi‑drug protocols.

What are the side effects of Oxaliplatin?

Oxaliplatin may …

Common Side Effects: - N \\ \\ \\ ... ... ... ... ... ... ... - ...

What precautions apply to Oxaliplatin?

This …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →